COronary CoLLateralization in Type 2 diabEtic Patients With Chronic Total Occlusion (COLLECT)
The Development of Coronary Collateralization in Type 2 Diabetic Patients With Chronic Total Occlusion
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Ying Shen, PhD
- Phone Number: 18601683266
- Email: rjshenying@qq.com
Study Contact Backup
- Name: Linshuang Mao
- Phone Number: 13736051345
- Email: mlshuang25@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200025
- Recruiting
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
-
Contact:
- Ying Shen
- Phone Number: 18601683266
- Email: rjshenying@qq.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18-90 years
- Type 2 diabetes diagnosed by one of the following criteria:
HbA1c >/= 6.5% Fasting plasma glucose >/= 7.0 mmol/l (confirmed) 2h plasma glucose value during OGTT >/= 11.1 mmol/l Already receiving glucose-lowering agents.
- At least one lesion with angiographic total occlusion
Exclusion Criteria:
- eGFR<15mL/(min·1.73m2)
- chronic heart failure with NYHA grade ≥3
- had a history of coronary artery bypass grafting
- had received a percutaneous coronary intervention within the prior 3 months
- Malignant tumor or immune system disorders
- Pulmonary heart disease
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
T2DM with good CCC
T2DM was diagnosed according to the criteria of the American Diabetes Association.
The diagnosis of CTO was made if at least one lesion was angiographic 100% occlusion.
Coronary collateral circulation development was graded according to the Cohen-Rentrop method, grade 2 (partial filling of the epicardial segment by collateral vessels); grade 3 (complete filling of the epicardial artery by collateral vessels) were defined as good coronary collateral circulation.
|
Cardiac function was evaluated by echocardiography at one year follow-up.
|
|
T2DM with poor CCC
T2DM was diagnosed according to the criteria of the American Diabetes Association.
The diagnosis of CTO was made if at least one lesion was angiographic 100% occlusion.
Coronary collateral circulation development was graded according to the Cohen-Rentrop method, grade 0 (no filling of any collateral vessels) and grade 1 (filling of side branches of the artery to be perfused by collateral vessels without visualization of the epicardial segment) were defined as poor coronary collateral circulation.
|
Cardiac function was evaluated by echocardiography at one year follow-up.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac function evaluated by echocardiography
Time Frame: 12 months
|
Assessed by echocardiography
|
12 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular events
Time Frame: up to 5 years
|
The incidence of MACCE (major adverse cardiac and cerebrovascular events)
|
up to 5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- sy11218
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.